GlassScriptPhysician profile
Mark W Kubik
NPI 1881937340
$4,102.36
in general payments reported to CMS, 2019-2025
9 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2021: $2,634 · 2022: $91.33 · 2023: $944 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $800 · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $800.49 |
| Food and Beverage | $305.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $2,150.00 | 2021 | |
| Stryker Corporation | $800.49 | 2023 | Xpress Ent Dilation System, Scopis Ent |
| Medical Device Business Services, INC. | $465.56 | 2021 | |
| Acera Surgical, INC. | $162.37 | 2025 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $143.35 | 2023 | Matrixmidface, Matrixmandible |
| Integra Lifesciences Corporation | $136.78 | 2019 | |
| Cook Medical LLC | $108.30 | 2019 | |
| Checkpoint Surgical, INC | $91.33 | 2022 | |
| Baxter Healthcare | $44.18 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kubik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.